| Path | Language | Actions |
|---|---|---|
| https://www.redhillbio.com/news/news-details/2022/RedHill-Biopharmas-Oral-Opaganib-Significantly-Imp... | - | Details HTML |
| https://www.redhillbio.com/news/news-details/2022/RedHill-Biopharma-Announces-Proposed-Public-Offeri... | - | Details HTML |
| https://www.redhillbio.com/news/news-details/2022/RedHill-Reports-Potent-Inhibition-of-Omicron-with-... | - | Details HTML |
| https://www.redhillbio.com/news/news-details/2024/RedHill-Announces-New-USPTO-Patent-Grant-for-Talic... | - | Details HTML |
| https://www.redhillbio.com/news/news-details/2023/RedHill-Biopharma-Provides-H123-Financial-Results-... | - | Details HTML |
Only the first 5 pages are shown. Log in or create a free account to browse all pages for this domain.
Log in Create account